Giant pharmaceutical GSK announces positive data for Endometrial cancer drug Dostarlimab
GlaxoSmithKline (GSK) oncology subsidiary Tesaro has unveiled promising data from its Phase I/II Garnet study evaluating dostarli...Read More
Showing posts with label positive data for Endometrial cancer. Show all posts
Showing posts with label positive data for Endometrial cancer. Show all posts
Subscribe to:
Posts
(
Atom
)
